Does Lexapro Cause Overactive Bladder Symptoms?
Lexapro (escitalopram) does not typically cause overactive bladder (OAB) symptoms; however, it can paradoxically cause urinary retention, particularly in elderly men with benign prostatic hyperplasia, and emerging evidence suggests it may actually improve OAB symptoms in certain contexts.
Understanding the Urinary Effects of Escitalopram
The relationship between escitalopram and lower urinary tract symptoms is complex and differs from typical OAB pathophysiology:
Urinary Retention Risk (Not OAB)
The FDA label for Lexapro does not list OAB symptoms (urgency, frequency, urgency incontinence) as recognized adverse effects 1
Escitalopram has been associated with acute urinary retention (AUR), which is the opposite of OAB symptoms 2, 3
Case series demonstrate that elderly men with known or latent benign prostatic hyperplasia developed AUR after starting standard doses of escitalopram, with resolution occurring after drug discontinuation 2
One case required emergent prostatectomy due to escitalopram-induced urinary retention 2
Mechanism of Urinary Effects
Escitalopram inhibits detrusor contractility through L-type calcium channel blockade, which would theoretically reduce bladder overactivity rather than cause it 4:
Laboratory studies show escitalopram significantly reduces carbachol-induced, KCl-induced, and electrical field stimulation-induced contractions in mouse detrusor strips 4
This calcium channel blocking effect relaxes the bladder muscle, opposing the pathophysiology of OAB 4
Potential Therapeutic Benefit for OAB
Recent animal research suggests escitalopram may actually improve OAB symptoms when they co-occur with depression 5:
In a rat model of co-existing depression and OAB induced by corticosterone, escitalopram (10 mg/kg/day) significantly improved bladder capacity, inter-contraction interval, and bladder compliance 5
These improvements were superior to traditional OAB medications (solifenacin and mirabegron) in this model 5
This suggests escitalopram may offer dual benefits for patients with both depression and OAB 5
Clinical Implications
What to Monitor
Watch for urinary retention symptoms (difficulty initiating urination, weak stream, incomplete emptying) rather than OAB symptoms when prescribing escitalopram 2, 3
Elderly male patients with known or suspected prostatic enlargement are at highest risk for escitalopram-induced urinary retention 2
Common Pitfalls to Avoid
- Do not confuse urinary retention with OAB—they represent opposite ends of the bladder dysfunction spectrum
- The most common urinary side effect listed in the FDA label is related to sexual dysfunction (delayed ejaculation), not voiding symptoms 1
- If a patient on escitalopram develops new urinary symptoms, consider retention first, particularly in older men 2, 3
When OAB Symptoms Occur
If a patient on escitalopram reports urgency, frequency, or urgency incontinence:
These symptoms are likely unrelated to the escitalopram and should be evaluated as idiopathic OAB per standard guidelines 6, 7
Standard OAB treatment with antimuscarinics or beta-3 agonists remains appropriate 6
Consider that escitalopram's detrusor-relaxing properties might theoretically complement OAB treatment 4